Document is current
Any future updates will be listed below
-
Authors
La Rosa, Federica
Montecucco, Fabrizio https://orcid.org/0000-0003-0823-8729
Liberale, Luca
Sessarego, Marta
Carbone, Federico
-
Funding
Funding for this research was provided by:
Ministero della Salute (RCR-2022-23682288 - Rete CARDIOLOGICA- Integrated strategies for the study of tissue, molecular determinants of vulnerable atherosclerotic plaque - Procedura nota DGRIC n. 1401 del 13/04/2022 Fondo progetti reti EF 2022’)
Ministero dell’Istruzione, dell’Università e della Ricerca (NEXTGENERATIONEU (NGEU), funded by the Ministry of University, Research (MUR), National Recovery, Resilience Plan (NRRP), project MNESYS (PE0000006) - (DN. 1553 11.10.2022).., NEXTGENERATIONEU (NGEU), funded by the Ministry of University, Research (MUR), National Recovery, Resilience Plan (NRRP), project MNESYS (PE0000006) - (DN. 1553 11.10.2022)..)
Università degli Studi di Genova
- License Information
-
More Information
Article History
Received: 3 July 2024
Accepted: 4 September 2024
First Online: 13 September 2024
Declarations
:
: The work of John Ioannidis is supported by an unrestricted gift from Sue and Bob O’Donnell to Stanford University. The other authors declare they have no conflict of interest. As a review article this is the only applicable statement.
: Luca Liberale is co-inventor on the international patent WO/2020/226993 filed in April 2020. The patent relates to the use of antibodies which specifically bind IL-1α to reduce various sequelae of ischaemia–reperfusion injury to the central nervous system. Luca Liberale reports speaker fees from Daiichi-Sankyo outside the submitted work and has received funding from the Novartis Foundation for Medical-biological Research (unrelated to this work).
